If You Missed Tesla, Here's Your "Second Chance"...

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Nextcure Stock Skyrockets Nearly 45% In After-Hours Trading After Sharing Preclinical Data For Brittle Bone Disease

Mohd Haider
July 24, 2025

NextCure Inc. (NASDAQ:NXTC) stock surged by 44.87% to $7.62 in after-hours trading on Thursday. 

Check out how the NTXC stock is trading here

What Happened: The surge in NextCure’s stock value came after the company presented new preclinical data for NC605, a potential treatment for brittle bone disease. 

Earlier in the day, the company’s shares were already trading higher after the presentation of the new preclinical data for NC605. The data demonstrated that treatment with NC605 improved bone microarchitecture and reduced fracture incidence compared to anti-sclerostin treatment in a well-established model of osteogenesis imperfecta.

Priyanka Kothari, NextCure's Director, stated, "NC605 has the potential to provide significant therapeutic benefit for patients."

See Also: Lockheed Martin Confirms Talks With US Over Trump’s $175 Billion ‘Golden Dome’ Missile Shield -- CEO James Taiclet Says No Contracts Yet, LMT Is ‘All In’

The Maryland-based biopharmaceutical company closed on Thursday at $5.26 and has traded between $2.80 – $20.76 over the past year. NextCure stock carries a market capitalization of $14.08 million, according to data from Benzinga Pro.

Why It Matters: NextCure has been making significant strides in its research and development efforts. The company recently announced a strategic partnership with Simcere Zaiming to develop SIM0505, a CDH6-targeting antibody-drug conjugate for solid tumors. This partnership is expected to advance NextCure’s oncology pipeline.

However, the company’s stock has been on a rollercoaster ride. Earlier in July, NextCure enacted a 1-for-12 reverse stock split, and its shares began trading on an adjusted basis. Despite this, the company’s stock has continued to show resilience and potential for growth.

Benzinga Edge Stock Rankings indicate that NXTC stock has a negative price trend across all time frames. Know how the stock fares on other parameters here.

Read Next:

  • Top 3 Energy Stocks Which Could Rescue Your Portfolio In July

Photo Courtesy: Mizkit on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Continue Reading...

Popular

Jim Cramer Recommends This 'Really, Really Good' Energy Stock

Cramer also looks at Shutterstock and Getty. One of these companies "doesn't really have the growth" that he'd like to see.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Trump's Bitcoin Reserve Just 'Legitimized It'—Coinbase CEO Brian Armstrong Says G20 Nations Now Rushing To Build Their Own BTC Stockpiles

Coinbase Global Inc. (NASDAQ:COIN) CEO Brian Armstrong said other G20 nations are now examining Bitcoin (CRYPTO: BTC) reserves following President Donald Trump‘s establishment of a St

Why Is Donald Trump Ignoring Elon Musk's Call For 'Phase 2' Of The Epstein Files?

Musk's post questioning Trump's unfulfilled promise of Epstein-related disclosures reignites tensions over transparency in politics and tech.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

Warren Buffett's 2005 Warning Echoes Louder As Social Security Faces $18,100 Benefit Cut By 2033, CRFB Warns

Social Security faces dire future if Congress doesn't act. Analysis warns of 24% cuts in 7 years and insolvency for Medicare. Warren Buffett raised concerns 20 years ago.

Can Apple's Slim iPhone And Cheaper Macs Reverse The 2025 Stock Slump?

Apple is expected to rebound in the second half of 2025 with new product launches and strong momentum in its Services division. Analysts reaffirmed a Buy rating with a price forecast of $235.

$5 Stock Building Nvidia's AI Servers - Ad

Nuclear stocks gained 51% as energy vampires drain grids . $2B+ revenue, Big Tech pays rent . Massive power opportunity brewing.

Texas AG claimed three homes as primary residence. Democrats are being probed for similar issue

WASHINGTON (AP) — Texas Attorney General Ken Paxton and his wife, Angela, are longtime owners of a $1.5 million house in a gated community outside Dallas. In 2015, they snapped up a second home in Austin. Then another.

Tesla Rivals BYD, Toyota, VW, GM Accused Of Faking Car Sales In China To Hit Targets: Report

Auto brands in China accused of inflating sales figures amid fierce competition to meet sales targets, leading to misjudgment of demand.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

Mark Cuban Praised His 'Hustling' Son, But Told Kids: 'Figure Out Who You Are, You Don't Need To Follow In My Footsteps'

Jake Cuban embarked on an entrepreneurial journey reminiscent of his father's early business ventures by starting a side hustle selling candy at his school.

Hidden $5 AI Manufacturer Revealed - Ad

The company manufacturing Nvidia's AI servers trades under a secret name. AI revenue: $30B this year. Stock price: $5.

The Last Time This Warning Flashed, S&P 500 Crashed The Most Since 2008

A rare warning signal has reappeared in the market, with a low bull-bear spread and high investor indecision.

Celestica Stock Surges On Q2 Earnings Beat, Company Raises 2025 Outlook On 'Strengthening' Demand

Celestica announces financial results for the second quarter Monday after the bell. Here's a rundown of the supply chain solutions company's report.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

What's Going On With Builders FirstSource Stock Today?

Builders FirstSource beat Q2 EPS but missed on sales, cut its FY25 outlook, and saw margins shrink, sending shares down over 3%.

Federal Reserve likely to stand pat on rates this week, deepening the gulf between Powell and Trump

WASHINGTON (AP) — The Federal Reserve is expected to leave its short-term interest rate unchanged on Wednesday for the fifth straight meeting, a move that will likely underscore between how Chair Jerome Powell and his chief critic, President Donald Trump, see the economy.

If You Own Tesla Stock, This Might Change Everything - Ad

Jeff Brown, an early Tesla bull, warns of a strange "Tesla Glitch" uncovered by Wall Street legend Larry Benedict. This anomaly has preceded $25B-$100B swings in Tesla's value - and he's using it to anticipate moves without buying or shorting a single share.

After years of tough rules on liquids and footwear, US air travel may be on the cusp of a new era

NEW YORK (AP) — When limits on liquids were introduced at TSA checkpoints across the country in 2006, bins overflowed with bottled water, toothpaste, shaving cream and so much more. Nearly two decades later, travelers are much more accustomed to the “3-1-1” regulations" governing the size of the liquids they're flying with, but scenes of passengers guzzling a beverage before putting their bags through the screening machines are still common.

Back the Biotech Company Unlocking Mushroom Health Benefits for All - Ad

Functional mushrooms can boost mental, gut, and immune health-but people can't grow them at home. One company is making it easy with a patent-pending kitchen device. Think Nespresso, but for mushrooms. The functional mushroom market is projected to nearly double by 2030.

How Trump could use a building renovation to oust the Fed chair

WASHINGTON (AP) — President says he has finally found a way to achieve his goal of removing Federal Reserve Chair Jerome Powell, accusing him of mismanaging the U.S. central bank’s $2.5 billion renovation project.

Leaked Memo Reveals AI's Next Land Grab - Ad

The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.

Meta's Strong Revenues May Offset Concerns Over Soaring AI Investments: Analyst

Meta Platforms poised for market focus on expanding AI initiatives, with aggressive recruitment of top-tier AI professionals and elevated estimates for revenue and EPS.

Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study

Alkermes' alixorexton met key endpoints in a Phase 2 trial for narcolepsy type 1, showing strong efficacy and tolerability across all doses.

If You Missed Tesla, Here's Your "Second Chance"... - Ad

If you missed your shot at turning $1,000 into more than $18,000 when I recommended Tesla, you'll want to pay close attention. I'm 100% convinced Elon's "Agenda X" could make early investors rich. But you need to hurry, because Elon and Visa are moments away from launching.

Nvidia-Supplier Taiwan Semiconductor On A Roll, Profit Explodes With Strong Margin Growth

Taiwan Semiconductor (TSM) reports strong Q2 results and expects continued growth in demand for advanced processor technologies, with revenue guidance of $31.8 billion to $33.0 billion for Q3.

MicroVision Tech On Nvidia Platform — What's Going On?

MicroVision's lidar system is now supported by Nvidia's DRIVE AGX platform, accelerating its adoption in the autonomous vehicle market.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

Tesla Cybertruck Bet Not Paying Off? Ford, GM Outsell EV Giant

Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see declining demand.

Verizon Beats Expectations, Boosts Outlook — Here's Why Analysts Still See More Room To Grow

Verizon's Q2 results beat expectations, driven by wireless and broadband offerings. Analysts raised price targets, but net additions were lower.

Tap Into the $65B 'Shroom Boom' - Ad

People are rapidly discovering how mushrooms can enhance brain function, gut health, immunity, and more. The only thing holding them back? A simple way to grow them. Hypha Labs built a compact countertop device to solve exactly that.

One Tech Tip: How to clean your computer, earbuds and smartphone

LONDON (AP) — Smartphones, laptops, headphones and other electronic devices are essential for work and play in our daily lives. But all that time spent typing, scrolling or listening also means our devices gradually accumulate grime that needs to be cleaned off.

Pony AI Stock Dips Despite Major Shanghai Robotaxi Permit

Shares of autonomous driving firm Pony AI are trading lower Tuesday. The company announced Monday it secured a permit for driverless robotaxi services in Shanghai.

$5 Stock Building Nvidia's AI Servers - Ad

Nuclear stocks gained 51% as energy vampires drain grids . $2B+ revenue, Big Tech pays rent . Massive power opportunity brewing.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service